Eli Lilly (LLY) Shares Repurchased (2016 - 2025)
Historic Shares Repurchased for Eli Lilly (LLY) over the last 14 years, with Q4 2025 value amounting to $1.5 billion.
- Eli Lilly's Shares Repurchased fell 2659.33% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 billion, marking a year-over-year increase of 6432.0%. This contributed to the annual value of $4.1 billion for FY2025, which is 6432.0% up from last year.
- Eli Lilly's Shares Repurchased amounted to $1.5 billion in Q4 2025, which was down 2659.33% from $708.1 million recorded in Q3 2025.
- Over the past 5 years, Eli Lilly's Shares Repurchased peaked at $2.1 billion during Q4 2024, and registered a low of $446.1 million during Q3 2024.
- For the 5-year period, Eli Lilly's Shares Repurchased averaged around $1.0 billion, with its median value being $750.0 million (2021).
- In the last 5 years, Eli Lilly's Shares Repurchased plummeted by 5000.0% in 2023 and then skyrocketed by 5873.12% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Shares Repurchased stood at $750.0 million in 2021, then surged by 100.0% to $1.5 billion in 2022, then tumbled by 50.0% to $750.0 million in 2023, then soared by 173.85% to $2.1 billion in 2024, then decreased by 26.59% to $1.5 billion in 2025.
- Its last three reported values are $1.5 billion in Q4 2025, $708.1 million for Q3 2025, and $692.2 million during Q2 2025.